기업명 | 주식 심볼 | 시장 | 주식 타입 |
---|---|---|---|
Connect Biopharma Holdings Inc | CNTB | 나스닥 | 주식예탁증서 (DR) |
개장가 | 저가 | 고가 | 종가 | 전일 종가 |
---|---|---|---|---|
1.37 |
최근 뉴스
일자 | 시간 | 출처 | 제목 |
---|---|---|---|
28/02/2024 | 11:00 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |
14/02/2024 | 06:30 | EDGAR2 | Form SC 13D - General statement of acquisition of beneficial.. |
14/02/2024 | 06:27 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
14/02/2024 | 06:18 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
13/02/2024 | 06:50 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
12/12/2023 | 20:10 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
21/11/2023 | 20:13 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
02/11/2023 | 04:57 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
21/10/2023 | 05:44 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
13/09/2023 | 05:47 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
12/09/2023 | 19:13 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
15/07/2023 | 06:00 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |